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Abstract 
Background: The pro‑inflammatory S100 calcium binding protein A8 (S100A8) is elevated in the serum of patients 
with Plasmodium falciparum malaria, but its function in Plasmodium vivax malaria is not yet clear. This function was 
investigated in P. vivax‑infected patients in this study.
Methods: The level of S100A8 in the serum was measured with ELISA. Full amino acids of S100A8 were synthesized 
to verify the functions for maturation of immature dendritic cell (iDC) and evaluation of CD4+CD25+Foxp3+ regula‑
tory T (Treg) generation by mature DC (mDC).
Results: A higher amount of S100A8 was detected in vivax‑infected patients (141.2 ± 61.849 ng/ml, n = 40) com‑
pared with normal control group (48.1 ± 27.384 ng/ml, n = 40). The level of S100A8 did not coincide with that of 
anti‑malarial antibody measured by indirect fluorescent antibody test (IFAT) using parasite‑infected red blood cells 
as antigen. Programmed death‑ligand 1 (PD‑L1) was up‑regulated on the surface of iDCs following treatment with 
synthetic S100A8, not with synthetic MSP‑1, AMA‑1 and CSP, as compared to the expression seen for non‑treated iDCs. 
The addition of red blood cells of infected patients to iDCs also elevated their surface expression of CD86. However, 
the serum levels of S100A8 decreased with increase in parasitaemia. DCs matured by sera containing S100A8 gener‑
ated Treg cells from naïve T cells. The ratio of Treg cells generated was inversely proportional to the concentration of 
S100A8 in sera.
Conclusions: Treg cells suppress the activity of cytotoxic T cells, which kill malaria parasites; therefore, the up‑regula‑
tion of S100A8 in malaria patients may contribute to pathogen immune escape or tolerance.
© 2015 Lee et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided 
you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate 
if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Malaria parasites are transmitted to the host via bites 
from anopheline mosquitoes, and then proceed to 
sequentially infect hepatocytes and red blood cells 
(RBCs) [1]. Disease symptoms begin with blood-stage 
infection, and can become chronic with sustained, low 
levels of blood-borne parasites [2]. In the blood, malaria 
parasites become exposed to professional antigen-pre-
senting cells (APCs) of the host immune system, which 
can then regulate the immunological response to facili-
tate pathogen clearance [3]. Dendritic cells (DCs) are 
specialized antigen-presenting cells that capture, pro-
cess and present antigens to T cells [4]. The outcome of 
the encounter between these two cell types depends on 
the activation status of the DC. In the steady state, anti-
gen presentation by DCs leads to tolerance by T cell 
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deletion, induction of anergy, or expansion of antigen-
specific CD4+CD25+Foxp3+ regulatory T (Treg) cells 
[5–8]. This sub-set of cells constitutively expresses CD25 
[9], the transcription factor Foxp3 [10–12], and other T 
cell markers such as cytotoxic T-lymphocyte-associated 
protein 4 (CTLA-4) and glucocorticoid-induced TNFR-
related protein (GITR) [13].
The S100 calcium binding protein A8 (S100A8), also 
known as myeloid-related protein 8 (MRP8) or calgranu-
lin A, belongs to the calcium-binding S100 protein family 
and forms Ca2+-dependent heterodimeric/heterotetra-
meric complexes with S100A9 (MRP14/calgranulin B). 
Human S100A8 is 93 amino acids (aa) long (10.8  kDa) 
and contains two EF-hand motifs (aa 12–47 and 46–81) 
and one high-affinity Ca2+ binding site (aa 59–70). Dur-
ing acute and chronic inflammation, S100A8 is expressed 
in granulocytes, monocytes and macrophages [14] and 
is released from damaged cells or activated phagocytes 
to act as a danger signal to potentiate pro-inflammatory 
responses within the vascular endothelium. Thus, S100A8 
is often classified as a damage-associated molecular pat-
tern (DAMP) molecule or alarmin, which is released by 
activated or damaged cells under conditions of cell stress, 
a group that also includes S100A9, high mobility group 
box-1 (HMGB1) and serum amyloid A (SAA), and which 
are closely related to several forms of disease, includ-
ing sepsis, arthritis, atherosclerosis, and cancer [15–18]. 
S100A8 is suggested to play a pro-inflammatory role in 
the innate immune response, but transitions to a regu-
latory function in adaptive immunity, which may be an 
important mechanism to avoid inflammation-induced 
tissue damage [19]. Furthermore, previous reports have 
shown that 84.7  % of patients with falciparum malaria 
have high levels of S100A8 in their blood [20]. Plasmo-
dium vivax parasites can often obtain immune tolerance 
or elicit immune escape mechanisms, thereby leading to 
longer lifespans than Plasmodium falciparum parasites in 
human hosts in Korea. Therefore, the effects of S100A8 
on infection status in patients with P. vivax only were 




Thick blood films were prepared to determine the infec-
tivity of patient blood samples. The blood was fixed with 
methanol and stained with Giemsa diluted with buffered 
water at pH 7.2 to emphasize the parasite inclusions in 
the RBCs. To estimate the densities of blood-stage par-
asites, the number of asexual parasites observed in 200 
white blood cells (WBCs) was totalled and the parasite : 
WBC ratio was multiplied by 8000 (assumed number of 
WBCs/μl blood) [21].
Ethics statement
All participants, including healthy adult blood donors, 
were informed about the methodology and signed an 
informed consent form according to ethical standards 
set by the Human Ethics Committee of Korea National 
Institute of Health approved. The study was conducted 
according to the principles expressed in the Declaration 
of Helsinki, and the study procedures, potential risks and 
benefits were explained to all investigators. Furthermore, 
all the data were blinded for analysis, and all patient 
names were excluded.
Detection of S100A8 in sera
The MRP8/14 (Calprotectin) Enzyme Immunoassay kit 
(BMA Biomedicals, Rheinstrasse, Switzerland) was used 
to determine the level of S100A8 in serum samples [20]. 
In brief, samples were diluted with assay buffer (1:100, 
v/v) and 100 μl was added to each well of a microtitre 
plate pre-coated with S100A8 monoclonal antibody. The 
plates were sealed and incubated for 16 h at 4  °C. Wells 
were washed six times with phosphate-buffered saline 
(PBS) prior to the immediate addition of 200 μl substrate 
buffer containing tetramethylbenzidine (TMB) and H2O2 
solution for 2 min at room temperature. The colour reac-
tion was stopped by adding 100 μl stop solution to each 
well. The absorbance was read at 450 nm with the refer-
ence wavelength set to 650  nm. Serially diluted stand-
ard solutions were run for each reaction to calculate the 
amount of S100A8 protein in each sample.
Indirect fluorescent antibody test
To test for antibodies against malaria, indirect fluorescent 
antibody tests (IFATs) were performed with whole blood 
antigen against P. vivax [22]. Briefly, 10  ml of malaria 
parasite-infected blood was collected by venipuncture 
from P. vivax patients. After removing the plasma, the 
cells were suspended in PBS (pH 7.2) and centrifuged for 
5 min at 2500 rpm. The supernatant was discarded, and 
the cells were resuspended in fresh PBS. The wash step 
was repeated three more times. Finally, an appropriate 
amount of PBS was added to maintain the parasite con-
centration at no less than 1 %. Cells were then added to 
each well of Teflon-coated slides and dried at room tem-
perature for 12 h prior to storage at −70 °C. To determine 
the antibody titres against P. vivax for each patient, the 
antigen slides were fixed in pre-cooled acetone (−20 °C) 
for 10 min and washed with PBS; then, 20 µL of diluted 
sera (1:32–1:8192 vol/vol) in PBS was added to each well. 
Positive and negative controls were spotted onto each 
slide and incubated in a humidified chamber for 30 min 
at 37 °C. Reactions were stopped by washing the reacted 
sera with PBS. The slides then were immersed in PBS 
for 6  min and then dried at room temperature. Diluted 
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FITC-conjugated anti-human IgG (Sigma, 1:32 vol/vol 
in PBS) was added to each well, incubated and washed 
using the same method described above. Several drops 
of buffered glycerol were added to the samples, and the 
slides were covered with coverslips. Slides were examined 
under the 40× objective of a fluorescence microscope.
Preparation of crude RBC
To obtain the crude RBC antigen from normal and P. 
vivax infected patient’s RBC, RBCs were frozen and 
thawed three times in −20  °C and room temperature 
and then centrifuged at 12,000×g for 30 min at 4 °C. The 
resultant supernatant fluid was filtered through a 0.22 µm 
membrane filter (Millipore Co, Billerica, MA, USA) with 
syringe, and used as crude RBC antigen.
Preparation of synthetic peptides
S100A8 peptides was synthesized by 9-fluorenylmeth-
oxycarbonyl (Fmoc) solid phase peptide synthesis (SPPS) 
using ASP48S (Peptron Inc, Taejeon, Korea) and purified 
by the reverse phase HPLC with a Vydac Everest C18 col-
umn (250 mm × 22 mm, 10 μm). Elution was carried out 
with a water-acetonitrile linear gradient (2–40 %, v/v, of 
acetonitrile) containing 0.1  % (v/v) trifluoroacetic acid. 
Molecular weights of the purified peptides were con-
firmed using LC/MS (Agilent HP1100 series, Waldbronn, 
Germany). In addition, partial amino acid sequences for 
merozoite surface protein-1 (MSP-1; DYDVVYLKPLAG-
MYK) [23], apical membrane antigen 1 (AMA-1; SAS-
DQPTQYEEEMTDYQK) [24], and circumsporozoite 
protein (CSP; GDRADGQPA) [25] of P. vivax, which are 
well characterized as vivax malaria vaccine candidates, 
were synthesized to compare the function of S100A8 
in  vitro assays or eliminate the background as synthe-
sized with the same method in the same company. The 
S100A8 peptide (MLTELEKALNSIIDVYHKYSLIKGN 
FHAVYRDDLKKLLETECPQYIRKKGADVWFKELD 
INTDGAVNFQEFLILVIKMGVAAHKKSHEESHKE) 
was designed based on GenBank no. CR407674.1. SPPS 
involves repeated cycles of coupling-wash-deprotec-
tion-wash to remove excess reagent. In peptide syn-
thesis, Fmoc-Glu(OtBu)-Wang resin is swollen by 
dichloromethane (DCM) for 30  min at room tempera-
ture, after which the DCM is extracted and the resin is 
washed with dimethylformamide (DMF) several times. 
The amino fmoc group is then deprotected by piperi-
dine, washed by DMF, and reacted with the carbonyl 
group of the next amino-protected amino acid Fmoc-
Val-OH, with the help of coupling reagents and activa-
tor for 30 min. Kaiser tests are used to detect free amino 
groups. When the solution did not change colour, the 
previous procedure was repeated. This cycle is repeated 
to form the desired peptide chain. After all reactions 
are complete, the synthesized peptide is cleaved from 
the resin with reagent K, precipitated with the addition 
of cold diethyl ether (DEE), washed with cold DEE, and 
dried in vacuum to a constant weight. Electrospray ioni-
zation mass spectroscopy (ESI–MS) was performed in a 
WATERS ZQ2000 instrument to detect the crude sample 
prior to purification by HPLC (Beijing Chuang Xin Tong 
Heng Science and Technology Co. Ltd, LC3000).
DC generation and maturation test
Buffy coats were obtained from healthy donors accord-
ing to the institutional guidelines of Korea National 
Institute of Health. Peripheral blood mononuclear cells 
(PBMCs) were prepared by density centrifugation using 
Ficoll-Paque gradients (Amersham Pharmacia Biotech, 
Uppsala, Sweden). The PBMCs were mixed with micro-
bead-conjugated anti-CD14 antibody (Miltenyi Biotech, 
Auburn, CA, USA) and then incubated on ice for 30 min. 
After washing with binding buffer (2  % FBS, 2  mM 
EDTA, 20 mM PBS, pH 7.4), CD14+ cells were purified 
by autoMACS (Miltenyi Biotech). The purified cells were 
subsequently cultured in six-well plates in RPMI 1640 
medium supplemented with 10  % heat-inactivated FBS, 
10 mM HEPES, 2 mM l-glutamine, 100 U/ml penicillin, 
10 µg/ml streptomycin, 50 μM 2-mecaptoethanol, 5 ng/
ml granulocyte–macrophage colony-stimulating factor 
(GM-CSF; R&D Systems, Minneapolis, MN, USA), and 
10  ng/ml IL-4 (R&D). To test the effect of S100A8 on 
DC maturation, immature DCs (iDCs) were harvested 
on day 3 and cultured with synthetic S100A8, CSP, MSP-
1, AMA-1, and lipopolysaccharide (LPS) for 48  h. DC 
maturation was assessed by the presence of CD86, PD-L1 
and HLA-DR on the DC surface, as determined by flu-
orescence-activated cell sorting (FACS) analysis using a 
FACSCalibur instrument (BD Biosciences, San Jose, CA, 
USA).
Treg cell induction by mature DCs
To isolate naïve T cells (CD4+CD25−Foxp3−), PBMCs 
were prepared from 30  ml of peripheral blood from 
healthy volunteers using density centrifugation by Ficoll-
Paque gradients. Naïve T cells were isolated using a 
human naïve CD4+ T cell isolation Kit II (Miltenyi Bio-
tech) according to the manufacturer’s instructions and 
separated on an AutoMACS sorter (Miltenyi Biotech). 
The unlabelled CD4+CD25− population (>98  % pure) 
was then used for Treg cell generation assays. To gener-
ate Treg cells, synthetic peptide-matured DCs and blood 
samples were cultured in 96-well plates at 1 × 106 cells/
ml in culture medium (RPMI 1640 supplemented with 
20 % heat-inactivated FBS, 2 mM l-glutamine, 100 U/ml 
penicillin, 10  µg/ml streptomycin) and stimulated with 
anti-CD3 (OKT3, 200 ng/ml; Janssen-Cilag, Raritan, NJ, 
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USA) and soluble anti-CD28 (200 ng/ml; BD Biosciences) 
monoclonal antibodies in the presence of 100 U/ml rIL-2 
and analysed 5 days later. Cells activated similarly in the 
presence of solely rIL-2 or in the absence of any synthetic 
peptides and blood samples served as controls. In some 
experiments, cells were stained with the fluorescent dye 
carboxyfluorescein succinimidyl ester (CFSE) (Life Tech-
nologies, Grand Island, NY, USA), prepared using the 
manufacturer’s protocol, to monitor proliferation.
Flow cytometric analysis
iDCs were stimulated with LPS, synthetic S100A8, MSP-
1, CSP and AMA-1 peptides, blood, and sera of malaria 
patients or healthy controls at 37  °C for 48  h. Induced 
mature DCs were then incubated with MHC class-II 
(HLA-DR)-FITC, CD86-PE, and PD-L1-APC specific 
antibodies on ice for 15  min, washed twice in staining 
buffer (PBS (pH 7.2) supplemented with 2  % FBS and 
0.1 % sodium azide), and fixed in PBS containing 1 % par-
aformaldehyde. CD4+ T cells were incubated with CD3-
Alexa Fluor 700, CD4-PE, and CD25-PE/Cy5 specific 
antibodies for 20 min at room temperature and washed 
with staining buffer. Intracellular staining for Foxp3 was 
performed following the manufacturer’s recommenda-
tions (BD Pharmingen). Briefly, the cells were incubated 
with 500 µl of 1× permeabilizing solution 2 (BD Bio-
sciences) for 10  min at room temperature in the dark, 
washed with staining buffer, and then incubated with 
Foxp3-APC antibody for 20  min at room temperature. 
After two additional washes in staining buffer, cells were 
fixed in PBS containing 1 % paraformaldehyde. Isotype-
matched control antibodies were included for all experi-
ments as controls for nonspecific binding. The dead cells 
were gated out by forward and side scatter. Flow cytome-
try was performed using a FACSCalibur (BD Bioscience) 
instrument, and the data were analysed using FlowJo 
software (TreeStar, Ashland, OR, USA).
Measurement of cytokine levels
Plasma was obtained from vivax malaria patients and 
centrifuged for 15  min at 2500  rpm; 200 μl aliquots 
were stored at −80 °C until use. Cytokine concentrations 
were measured in duplicate using a Bio-Plex Pro human 
cytokine multiplex assay kit (Bio-Rad, Hercules, CA, 
USA) according to the manufacturer’s instructions.
Statistical analysis
Data analysis was performed using GraphPad Prism ver-
sion 4.0 (GraphPad Software, San Diego, CA, USA). All 
values have been expressed as the mean ± standard devi-
ation (SD). A P value of <0.05 was considered statistically 
significant. The relationship between sera S100A8 con-
centrations and reciprocal antibody titer was compared 
using one-way ANOVA followed by the Kruskal–Wallis 
test. The induction of mature DCs by LPS and synthetic 
peptides and the cytokine production of these cells were 
compared using one-way ANOVA followed by Bonferro-
ni’s multiple comparison tests. DC maturation by patient 
sera and crude patient RBC antigens were compared 
using two-way ANOVA. The effect of synthetic peptides 
on Treg cell induction and S100A8 levels in sera among 
malaria patients and healthy controls were compared by 
t-test followed by Mann–Whitney test. The correlations 
between S100A8 serum concentration and parasitaemia 
in malaria patients on Treg cell induction were analysed 
by linear regression.
Results
Level of S100A8 in sera from Plasmodium vivax‑ infected 
patients
It is not known whether vivax malaria patients exhibit 
increased serum concentrations of S100A8, as seen with 
falciparum malaria patients [20]. Therefore, the concen-
trations of S100A8 in 40 malaria patients who were con-
firmed to be infected with Korean isolates of P. vivax was 
first measured and compared with those of 40 healthy 
controls (Fig.  1). The mean level of S100A8 detected 
was 141.2  ±  61.849  ng/ml in P. vivax-infected patients 
and 48.1  ±  27.384  ng/ml in the normal control group 
(P  <  0.0001). To determine if any correlation existed 
between S100A8 concentrations and anti-malaria antibody 
titres, IFAT assays using P. vivax-infected RBC antigen 
were used to assess the presence of anti-malaria anti-
bodies in the sera. Interestingly, the level of S100A8 did 



















Fig. 1 Expression of S100A8 in Plasmodium vivax‑infected patients. 
Comparison of S100A8 concentrations in the sera of patients and 
healthy controls. The concentrations of S100A8 in blood samples 
were measured with a MRP8/14 Enzyme Immunoassay kit
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P =  0.8806). It was expected that S100A8 concentration 
might correlate with parasitaemia; however, S100A8 con-
centrations were significantly decreased in patients with 
increased levels of parasitaemia (Fig. 3, P = 0.0199).
Function of S100A8 in DC maturation
To determine the effect of S100A8 on DC maturation, 
immature myeloid DCs were generated by culturing 
CD14+ PBMCs in the presence of GM-CSF and IL-4 for 
3  days, followed by incubation with synthetic S100A8, 
MSP-1, AMA-1, CSP, and LPS for 48  h. Expression of 
the DCs’ maturation markers, CD86, HLA-DR and 
PD-L1, were then assessed by flow cytometric analysis. 
When comparing the expression levels of HLA-DR and 
PD-L1, 14.3  % of the untreated controls were found to 
be double-positive, whereas LPS induced high levels 
of expression on the iDC surface, with 82.5  % of cells 
being double-positive, followed by 45.5  % cells showing 
positivity for S100A8, 35.8 % for CSP, 29.0 % for AMA-
1, and 19.5  % for MSP-1 (Fig.  4). LPS (P  <  0.001) and 
synthetic S100A8 (P  <  0.05) displayed significant eleva-
tions of CD86, HLA-DR and PD-L1; however, the CSP, 
MSP-1 and AMA-1 synthetic peptides were found to 
have no significant effect on induction on comparison 
with control, untreated iDCs (Fig. 5). The effect of para-
site-infected RBCs (Fig. 6) containing S100A8, as verified 
by ELISA, were then tested on DC maturation. Notably, 
infected RBCs’ crude antigen significantly increased the 
expression of CD86 on iDCs (P = 0.0019, n = 5, Fig. 6b). 
It means that some components of malaria parasites may 
directly affect DC maturation or induce the expression of 
S100A8 in iDC, which is used in DC maturation as self-
feeding manner to be matured DC.
Mature DCs generate Treg cells
The combined blockade of PD-L1 and lymphocyte-acti-
vation gene 3 (LAG-3) accelerates the clearance of yoelii 
malaria and correlates with improved CD4+ T cell and B 
cell responses [26]. However, since PD-L1 can interact 
specifically with both B7-1 [27] and PD-1 [28] to inhibit 
T cell activation, either pathway—individually or coop-
eratively—could contribute to the attrition of malarial 
immunity. Therefore, further analysis of the functional 
status of matured DCs in healthy volunteers was exam-
ined by measuring their capability to induce Treg cells. 
Significantly, the presence of LPS (67.4  %) and S100A8 
(65.2 %) induced Treg cells as much as two times higher 
than non-treated control cells (24.8  %, Fig.  7a). When 
Treg generation was tested with seven volunteers’ DC, 
control group showed Treg generation as 18 ±  14.13  % 
and sS100A8-treated group (29.40  ±  14.90  %) showed 
higher than LPS-treated group (27.93  ±  16.70  %) 
(Fig.  7b). Furthermore, naïve T cells cultured with 
S100A8-containing sera led to Treg cell generation 
that was inversely proportional to the concentration of 
S100A8 in the sera (Fig. 8, P = 0.0245, n = 10). Interest-
ingly, synthetic S100A8 always increased the induction 
of Treg cells in PBMCs isolated from healthy volunteers 
(Fig.  9d, P =  0.0465), but was not constant in synthetic 
MSP-1, AMA-1 and CSP treatments (Fig. 9a–c).
Cytokine production by mature DCs
IL-10 and IL-12p70 were significantly elevated in mature 
DCs following treatment with synthetic S100A8, com-
pared to other vaccine candidate peptides (Fig.  10c, d, 





















Fig. 2 Expression of S100A8 in Plasmodium vivax‑infected patients. 
Relationship between S100A8 concentration and reciprocal antibody 
titer in sera against P. vivax. Antibody titres were measured by the 






























Fig. 3 Expression of S100A8 in Plasmodium vivax‑infected patients. 
S100A8 expression in patients with P. vivax, according to their para‑
sitaemia. A P value of <0.05 was considered statistically significant. 
The relationship between S100A8 concentrations and reciprocal 
antibody titre in sera was compared using one‑way ANOVA followed 
by the Kruskal–Wallis test. S100A8 expression in patients according to 
parasitaemia was analysed by linear regression
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tumour necrosis factor (TNF), and interferon-γ (IFN-γ) 
also increased, but the differences were not statistically 
significant (Fig. 10a, b, e, f ).
Discussion
The severity of malaria can range from asympto-
matic to lethal infections involving severe anaemia 
Control                                LPS                                 sS100A 8





Fig. 4 Comparison of the DC maturation state between LPS and synthetic peptides, S100A8, CSP, AMA‑1, and MSP‑1. The maturation state of imma‑






























































































Fig. 5 Comparison of the DC maturation state between LPS and synthetic peptides, S100A8, CSP, AMA‑1, and MSP‑1. DC maturation as determined 
by the expression levels of CD86, HLA‑DR, and PDL‑1 by several synthetic peptides. The relative increase in surface expression is expressed as the 
mean fluorescence intensity (MFI) of matured DCs over the MFI of iDCs. A representative result of three repeated experiments is shown for FACS 
analysis. Significant differences were determined using one‑way ANOVA followed by Bonferroni’s multiple comparison tests (*P < 0.05, **P < 0.01, 
***P < 0.001)
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and cerebral disease; however, the molecular and cel-
lular factors responsible for these differences are poorly 
understood. Thus, identifying the factors that mediate 
virulence will contribute to developing antiparasitic 
therapy. Similar to the findings for other infectious dis-





































































Fig. 6 DC maturation by crude antigens of red blood cell infected with Plasmodium vivax. iDC untreated control DC, Pos RBC malaria positive red 
blood cell treated DC, Neg RBC normal healthy volunteer’s red blood cell treated DC. DC maturation was assessed by the levels of a PD‑L1, b CD86 
and c HLA‑DR on the DC surface as measured by fluorescence‑activated cell sorting (FACS). The relative increase in surface expression is expressed 
as the mean fluorescence intensity (MFI) of matured DCs over the MFI of iDCs. A representative result of three repeated experiments is shown. 
Significant differences were determined using the two‑way ANOVA (*P < 0.05, **P < 0.01, n = 5)





































Fig. 7 CD4+CD25+Foxp3+ regulatory T (Treg) cell generation by synthetic S100A8. Naïve T cells (CD4+CD25−Foxp3−) were isolated from the 
peripheral blood of healthy volunteers and stimulated with anti‑CD3 and anti‑CD28 monoclonal antibodies in the presence of 100 U/ml recombi‑
nant interleukin‑2 (rIL‑2) and/or synthetic peptides for 5 days. To monitor the cell proliferation, naïve T cells were stained with the fluorescent dye 
carboxyfluorescein succinimidyl ester (CFSE). Treg cell generation was evaluated by FACS analysis. a A representative result of FACS profile of Treg 
generation by LPS and sS100A8. b Significantly increased Treg generation by LPS and sS100A8 obtained by seven separate experiments with differ‑
ent volunteers’ DC each. Significant differences were determined using the one‑way ANOVA (*P < 0.05, **P < 0.01, n = 5)
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immune responses in malaria. Although DCs are known 
to be important for initiating immunity to malaria [29, 
30], studies describing the function of DCs in the adap-
tive response to infection have not explored their direct 
role in disease outcome, survival, anaemia, or parasi-
taemia. Furthermore, limited data exist on the differ-
ing outcomes of Plasmodium infections. Interestingly, 
the mean incubation period of Korean P. vivax isolates 
is reported to extend as long as 279  ±  41  days (range 
153–452  days) [31]. The ratio of cases with short and 
long incubation periods was 25 and 75  %, respectively 
[32]. As such, it was hypothesized that disease in patients 
with long incubation periods might be due to pathogens 
that have undergone immune escape or tolerance. It is 
mainly attributable to Treg cells that have a crucial role 
in immune suppression during malaria infection, as well 
as the escape of parasites from host immune surveillance 
[33, 34].
Two main DC sub-sets have been characterized in 
humans, myeloid (mDC, CD11c+) and plasmacytoid 
DCs (pDCs, CD11c−) [35]. A sub-set of mDCs (also 
known as monocyte-derived DCs, MDDCs or mo-DCs) 
are differentiated from monocytes (CD14+) when cul-
tured in the presence of GM-CSF and IL-4 [36]. DCs 
express a wide repertoire of membrane receptors, includ-
ing pattern recognition receptors (PRRs) that induce their 
terminal differentiation and activation upon engagement 
by DAMPs or pathogen-associated molecular patterns 
(PAMPs) [37]. C-type lectin receptors (CLRs), a sub-type 
of PRRs, promote the activation of Syk and CARD9 and 
preferentially induce the polarization of naïve Th0 lym-
phocytes into Th17 cells [38–40]. In comparison, tolero-
genic DCs are able to inhibit the differentiation of naïve 
Th0 lymphocytes, thus suppressing the generation of T 
cell-mediated immune responses, and induce the genera-
tion of Treg cells [41, 42]. In this regard, it has been theo-
rized that different membrane receptors (e.g., PSGL-1 
and PD-L1), as well as cytokines (e.g., IL-10), are able to 
induce the generation of tolerogenic DCs [43, 44]. Since 
S100A8 is reported to promote the generation of Treg 
cells through the induction of tolerogenic DCs [45], the 
role of S100A8 was investigated in P. vivax patients. 
Notably, the amount of S100A8 in vivax malaria patients 
was three times higher than that in healthy volunteers 
(Fig. 1), and the mean value of S100A8 produced by vivax 
malaria patients (141.2 ng/ml) was less than that of falci-
parum malaria patients (3420 and 13,580 ng/ml for par-
asitaemia  <0.2 and ≥0.2  %, respectively) [20]. However, 
these levels did not correlate with the amount of antibod-
ies produced (Fig.  2). Interestingly, antibody titres were 
inversely correlated with parasitaemia (Fig.  3); however, 
the level of serum S100A8 was significantly related to 
the parasitic load in patients with P. falciparum, as well 
as fever episodes in children up to 6  years of age [20]. 
This observation emphasizes a potential difference in the 
function of S100A8 in P. vivax and P. falciparum patients. 
Comparison of the induction of PD-L1 and HLA-DR 
double-positive iDCs by several vaccine candidate pep-
tides and synthetic S100A8 showed that approximately 
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Fig. 8 Treg cell induction in the presence of S100A8‑containing sera. 
DCs matured in the presence of sera of malaria patients were co‑
cultured with naïve T cells stained with CFSE. Treg cell generation was 
evaluated by FACS analysis and analysed by linear regression
Fig. 9 Increased Treg cell induction in normal PBMCs on adding 
synthetic a CSP, b MSP‑1, c AMA‑1, d S100A8. PBMCs from healthy 
volunteers were cultured in the presence of 1 μg of each synthetic 
peptide and cultured for 5 days. Treg cell induction was then evalu‑
ated by FACS analysis. Significant differences were determined using 
the Mann–Whitney test (*P < 0.05, n = 5)
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half of the double-positive cells were induced by syn-
thetic S100A8 compared to LPS. The Pv210 type of 
synthetic CSP induced double-positive DCs with rela-
tively higher expression than that of AMA-1 and MSP-1 
(Fig.  4). This suggests that CSP might induce immune 
tolerance in some patients, but not in a statistically sig-
nificant manner (Fig.  5). As expected, parasite-infected 
RBCs from vivax malaria patients significantly induced 
DC maturation than in normal persons (Fig.  6). How-
ever, P. falciparum-infected RBC appeared to inhibit 
DC maturation, subsequently reducing its capacity to 
stimulate T cells [46]. Therefore, S100A8 in vivax malaria 
appears to promote its immune escape, as elevations in 
PD-L1 on the iDCs surface by synthetic S100A8 pro-
motes Treg cell induction greater than that observed in 
controls (Fig.  7). The serum levels of S100A8 decreased 
with increase in parasitaemia (Fig.  3) and the ratio of 
Treg cells generated was inversely proportional to the 
concentration of S100A8 in sera (Fig. 8). This means that 
S100A8 function is controlled by unknown factors in the 
sera for maintaining the immune balance or S100A8 con-
centration may reflect the beginning of onset. Therefore, 
the next goal is to investigate these factors or investiga-
tion of S100A8 concentration according to time course of 
disease onset which affect the Treg generation rate. Only 
synthetic S100A8 was sufficient to increase Treg cell 
induction from healthy volunteer PBMCs, whereas the 
CSP, MSP-1 and AMA-1 synthetic peptides were unable 
to mediate this effect (Fig. 9). In addition, IL-10 produc-
tion in iDCs increased significantly with the addition 
of synthetic S100A8 (Fig.  10). The immunoregulatory 
mechanisms involving IL-10 appear complex and involve 
both pro-inflammatory and suppressive functions, 
although the prime function of IL-10 is to protect the 
host from excessive immune and inflammatory responses 
[47]. Nevertheless, S100A8 plays a clear pro-inflamma-
tory function by facilitating the secretion of IL-1β, IL-





































































































































































































Fig. 10 Comparison of cytokine production in DCs matured in the presence of synthetic peptides. iDCs were stimulated with synthetic peptides for 
48 h and each supernatant was applied to Bio‑Plex Pro human cytokine multiplex assay plates. Ctrl; not treated iDC, CSP; synthetic circumsporozoite 
protein treated iDC, MSP‑1; synthetic merozoite surface protein‑1 treated iDC, AMA‑1; synthetic apical membrane antigen‑1 treated iDC, sS100A8; 
synthetic S100A8 treated iDC. Expression level of a IL‑1β, b IL‑2, c IL‑10, d IL‑12p70, e TNF‑α, and f IFN‑γ in matured DC by several synthetic peptides. 
Data were compared using one‑way ANOVA followed by Bonferroni’s multiple comparison tests. The experiment was performed in duplicate 
(*P < 0.05, **P < 0.01)
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the mouse, S100A8 acts as a potent chemo-attractant for 
neutrophils and monocytes in vitro and in vivo [48–50] 
to influence leukocyte migration and transmigration 
into tissues by increasing their deformability [51]. There-
fore, S100A8 likely plays dual roles in the inflammatory 
response depending upon the environmental conditions. 
Thus, synthetic S100A8 up-regulated the expression of 
HLA-DR, PD-L1, CD86, and IL-10 in DCs necessary for 
generating Treg cells, which contributes to escape from 
the host immune defences [52]. The presence of parasite-
specific CD4+ T cells correlates with reduced parasite 
burdens and disease severity in malaria, but the effect of 
parasites on Treg cell induction is the opposite [28]. The 
source of S100A8 in malaria remains unclear, although it 
is known to be secreted from monocytes, macrophages 
and neutrophils [53–58]. Petersen et  al. found that a 
novel mechanism of immune regulation mediated by 
S100A8 is an important factor in orchestrating coor-
dinated immune reactions. This observation allows for 
the propagation of an appropriate innate inflammatory 
response by acting as a classical DAMP protein, while 
also preventing hyper-activation of the adaptive immune 
system so as to avoid the tissue damage that can be 
caused by excessive immune responses [19]. S100A8 may 
exhibit pleiotropic effects and promote IL-10 secretion to 
elicit synergic effects that regulate harmful inflammatory 
tissue damage by virtue of its capacity to act as an anti-
oxidant [59], thereby protecting against acute cytokine-
mediated pathology.
Conclusions
These findings suggest that S100A8 provides an immune 
environment friendly toward vivax malaria parasites by 
elevating Treg, which suppress the parasite-activated T 
cells. Therefore, this kind of environmental change may 
contribute to the long-term persistence of P. vivax in 
human host.
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